CIK 0001281895 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue (USD) | 0 | 0 | ||
| Net income (USD) | -221.9 M | -169.1 M | -139.7 M | |
| Diluted EPS (USD/shares) | -2.01 | -2.92 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-06 | 8-K | 8-K items 1.01,2.03,3.02,7.01,9.01 | 2026-09-30 |
| 2026-09-15 | 4 | FORM 4 | 2026-09-11 |
| 2026-09-15 | 144 | 144 | |
| 2026-09-15 | 8-K | 8-K items 7.01,9.01 | 2026-09-15 |
| 2026-09-14 | 144 | 144 | |
| 2026-09-11 | 144 | 144 | |
| 2026-09-11 | 144 | 144 | |
| 2026-09-02 | 25-NSE | 25-NSE | |
| 2026-08-27 | 8-K | 8-K items 5.02 | 2026-08-21 |
| 2026-08-20 | 4 | 4 | 2026-08-18 |
| 2026-08-20 | 4 | 4 | 2026-08-18 |
| 2026-08-18 | 144 | 144 | |
| 2026-08-18 | 144 | 144 | |
| 2026-08-18 | 144 | 144 | |
| 2026-08-17 | 4 | FORM 4 | 2026-08-13 |
| 2026-08-17 | 4 | FORM 4 | 2026-08-13 |
| 2026-08-13 | 4 | FORM 4 | 2026-08-11 |
| 2026-08-13 | 4 | FORM 4 | 2026-08-11 |
| 2026-08-13 | 144 | 144 | |
| 2026-08-13 | 144 | 144 | |
| 2026-08-11 | 144 | 144 | |
| 2026-08-11 | 144 | 144 | |
| 2026-08-10 | 8-K | 8-K items 2.02,9.01 | 2026-08-10 |
| 2026-08-10 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-05 | 4 | 4 | 2026-08-03 |
Forms on file (last 1,000): 4 341, 8-K 148, 144 108, 3 45, SC 13G/A 37, 10-Q 35, SC 13G 24, 424B5 21. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=RCKT (0.002 USD), /gw/filings/filings?ticker=RCKT&form=8-K, /gw/filings/facts?ticker=RCKT&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange